French companies raise capital

From October 5 to October 11, 2026, thirteen French companies raised nearly 270 million euros in capital financing. Spiko, Wiremind, and Vates together accounted for more than half of the total amount. The investments addressed various needs, including scientific validation, industrial capacity, and the deployment of existing software. The fundraising included companies at different stages of development.

Spiko and Wiremind secure large sums

Spiko, based in Paris, announced 90 million dollars (about 79.9 million euros) to expand its monetary funds. Wiremind, also based in Paris, raised 35 million euros to support R&D and international expansion. Vates, based in Grenoble, raised 30 million euros for virtualization, sales teams, and partners. Other companies included WhiteLab Genomics and Rivercell, which raised significant amounts for their respective projects.

Other companies join the fundraising

Vocca, based in Paris, raised 20 million dollars (about 17.7 million euros) for the deployment of vocal agents in care. VoltR, based in Verrières-en-Anjou, raised 22 million euros, of which 16 million euros was in capital, for the industrialization of reconditioned batteries. Edonia, based in Bordeaux, raised 15 million euros, of which 12 million euros was in investments, for the production of ingredients from microalgae.

Investors and partnerships

The fundraising included various investors, including NEA, which led the Series B of Spiko, and AVP, which led the round for WhiteLab Genomics. Bpifrance participated in four of the thirteen capital rounds through different vehicles. In industry, VoltR associated SPI 2 and Decathlon Pulse, while Edonia brought together SWEN Blue Ocean 2, Asterion Ventures, and EIT Food.

Focus on expansion and operations

Spiko, Wiremind, and Vates focused on expanding their operations. Wiremind, which develops software for managing revenues, capacities, and distribution for transportation and events, aimed to strengthen its R&D and international presence. Vates, which is profitable and self-financed since 2016, aimed to support its virtualization platform, sales teams, and partner network.

Health-focused projects

In health, each funding aimed to buy different proofs. WhiteLab Genomics aimed to continue in vivo validation of components of genomic therapies designed with AI and develop commercial partnerships. Rivercell aimed to produce its own experimental data, expand its Paris laboratory, and develop models capable of predicting the response of human cells to treatments.

Industrial and production goals

VoltR and Edonia must convert capital into production. VoltR announced 22 million euros to industrialize the reconditioning of lithium batteries, with 16 million euros invested in capital by SPI 2 and Decathlon Pulse, and 6 million euros in aid from the Première Usine program. Edonia announced 15 million euros in financing, of which 12 million euros in investments, to open a dedicated unit for its microalgae-based ingredient.

Business software and automation

Business software seeks a place in daily operations. Netsec, which raised more than 10 million dollars from investors led by Partech, aims to combine information technology and cybersecurity in a subscription billed per employee. Cleavr raises 8 million euros to automate the tracking of invoices until payment. Verso raises about 5.4 million euros to accelerate consumer studies. Fleuret AI closes this list with 4 million euros in pre-seed funding to develop agents capable of automating part of the penetration tests.